Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts.

Cancer research communications·2025
Same author

Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Journal for immunotherapy of cancer·2025
Same author

Improved Methods for the Stable Generation of Human Papillomavirus-Driven Head and Neck Cancer Cell Lines.

Molecular carcinogenesis·2025
Same author

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center.

Frontiers in oncology·2025
Same author

Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.

NPJ precision oncology·2025
Same journal

Acylglycerol Kinase Sensitizes Glioblastoma to Temozolomide via Limiting Mitochondrial Damage Related Cellular Senescence.

Molecular carcinogenesis·2026
Same journal

Accelerated Biological Aging Increases the Risk of Head and Neck Cancer: Insights From Genetic Instruments of Epigenetic Clocks.

Molecular carcinogenesis·2026
Same journal

Colorectal Cancer Liver Metastasis-Associated Ferroptosis-Related Genes Modulate Lipid Peroxidation in Colorectal Cancer Cells.

Molecular carcinogenesis·2026
Same journal

Ubiquitin Specific Peptidase 48 Deubiquitinates METTL3 to Modulate Ferroptosis in Gastric Cancer Cells.

Molecular carcinogenesis·2026
Same journal

Prevention of Myc-Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane.

Molecular carcinogenesis·2026
Same journal

Association of Expression of YTH-Domain Family Protein 3 (YTHDF3) With Brain Metastases and Unfavorable Survival in Patients With Stage IV Lung Adenocarcinoma.

Molecular carcinogenesis·2026
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.5K

The humanized mouse: Emerging translational potential.

J Jason Morton1, Nathaniel Alzofon1, Antonio Jimeno1,2

  • 1Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.

Molecular Carcinogenesis
|April 11, 2020
PubMed
Summary
This summary is machine-generated.

Humanized mouse models improve cancer research by mimicking the human tumor microenvironment (TME). Optimizing these models is crucial for developing effective immunotherapies and predicting patient responses.

Keywords:
PDXhumanizedimmunotherapy

More Related Videos

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on: December 18, 2012

19.2K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.7K

Related Experiment Videos

Last Updated: Dec 24, 2025

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.5K
Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on: December 18, 2012

19.2K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.7K

Area of Science:

  • Immunology
  • Oncology
  • Animal Models

Background:

  • Humanized mouse (HM) models are valuable for cancer research, enabling in vivo evaluation of the tumor microenvironment (TME).
  • These models can assess novel cancer treatments, including immune checkpoint inhibitors.
  • Ensuring representative tumor-immune interactions in HMs is critical for their utility.

Purpose of the Study:

  • To highlight the importance of optimizing humanized mouse models for cancer research.
  • To identify critical factors for harmonizing the immune-tumor environment in HMs.
  • To underscore the potential of refined HM models in discovering and predicting immunotherapy efficacy.

Main Methods:

  • Engrafting HMs with human immune system components.
  • Implanting HM models with human cell line or patient-derived xenograft tumor tissues.
  • Investigating strategies to harmonize the immune-tumor microenvironment in HMs.

Main Results:

  • Current HM models face challenges where human T cells may be allogeneic or alloreactive, potentially compromising tumor-immune interaction fidelity.
  • Ongoing strategies aim to harmonize the immune-tumor environment within HMs.
  • Understanding the HM-tumor TME interface is key to model optimization.

Conclusions:

  • Optimized HM models are essential for accurate in vivo assessment of tumor-immune interactions.
  • Refined HM models can facilitate the discovery of effective immunotherapies.
  • Improved HM models hold significant potential for predicting patient responses to cancer treatments, offering clinical benefit.